Resultats globals: 1 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
12 p, 823.0 KB Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation / Hodkinson, Brendan P. (Oncology Translational Research (Estats Units d'Amèrica)) ; Schaffer, Michael (Oncology Translational Research (Estats Units d'Amèrica)) ; Brody, Joshua D. (Icahn School of Medicine at Mount Sinai (Estats Units d'Amèrica)) ; Jurczak, Wojciech (Maria Sklodowska-Curie National Research Institute of Oncology) ; Carpio Segura, Cecilia del Carmen (Vall d'Hebron Institut d'Oncologia) ; Ben-Yehuda, Dina (Hadassah-Hebrew University Medical Center) ; Avivi, Irit (Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine) ; Forslund, Ann (Bristol-Myers Squibb) ; Özcan, Muhit (Ankara University School of Medicine) ; Alvarez, John (Janssen Research & Development, Spring Housen (Estats Units d'Amèrica)) ; Ceulemans, Rob (Translational Medicine, Janssen Research & Development) ; Fourneau, Nele (Translational Medicine, Janssen Research & Development) ; Younes, Anas (Memorial Sloan Kettering Cancer Center) ; Balasubramanian, Sriram (Janssen Research & Development (Estats Units d'Amèrica)) ; Universitat Autònoma de Barcelona
We analyzed potential biomarkers of response to ibrutinib plus nivolumab in biopsies from patients with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and Richter's transformation (RT) from the LYM1002 phase I/IIa study, using programmed death ligand 1 (PD-L1) immunohistochemistry, whole exome sequencing (WES), and gene expression profiling (GEP). [...]
2020 - 10.1016/j.tranon.2020.100977
Translational Oncology, Vol. 14 (december 2020)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.